Learn More
TARGETMOL CHEMICALS INC GALETERONE 25MG

Supplier: TARGETMOL CHEMICALS INC T650925MG
Also available in 5 mg 10 mg 50 mg 100 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Galeterone (VN 124) is an orally bioavailable small-molecule androgen receptor modulator and CYP17 lyase inhibitor with potential antiandrogen activity. Galeterone exhibits three distinct mechanisms of action 1) as an androgen receptor antagonist 2) as a CYP17 lyase inhibitor and 3) by decreasing overall androgen receptor levels in prostate cancer tumors all of which may result in a decrease in androgen-dependent growth signaling. Localized to the endoplasmic reticulum (ER) the cytochrome P450 enzyme CYP17 (P450C17 or CYP17A1) exhibits both 17alpha-hydroxylase and 17 20-lyase activities and plays a key role in the steroidogenic pathway that produces progestins mineralocorticoids glucocorticoids androgens and estrogens. purity: 99%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.